abstract |
The invention is directed to opioid delta receptor modulators; more specifically, the invention relates to tricyclic opioid modulators; Pharmaceutical and veterinary compositions and methods for treating mild to severe pain and various diseases using the compounds of the invention are also described; formula (I) (see formula (I)). |